CWM
ARQT icon

CIBC World Markets’s Arcutis Biotherapeutics ARQT Stock Holding History

CIBC World Markets’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$211K Buy
+7,282
New +$186K ﹤0.01% 1101
2025
Q2 		$185K Sell
13,197
-10,655
-45% -$149K ﹤0.01% 1302
2025
Q1 		$373K Buy
23,852
+13,793
+137% +$194K ﹤0.01% 1145
2024
Q4 		$140K Buy
+10,059
New +$110K ﹤0.01% 1175

Other funds holding ARQT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIBC World Markets's ARQT Position: Q4 2025 in Review

CIBC World Markets opened a new position in Arcutis Biotherapeutics (ARQT) in Q4 2025: 7,282 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #1101 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in ARQT as recently as Q2 2025.

CIBC World Markets first reported a position in ARQT in Q4 2024 and has held it in 4 quarters since. The position peaked at $373K in Q1 2025. 283 funds tracked by Wall St. Rank hold ARQT as of Q4 2025.

  • CIBC World Markets held 7,282 shares of Arcutis Biotherapeutics worth $211K as of Q4 2025.
  • Arcutis Biotherapeutics was a new CIBC World Markets position in Q4 2025.
  • Arcutis Biotherapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1101 holding.
  • CIBC World Markets first reported a position in Arcutis Biotherapeutics in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Arcutis Biotherapeutics position peaked at $373K in Q1 2025.
  • 283 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.